Ocean Biomedical, Inc. (OCEA)
OCEA moved a median of -1.45% 30 minutes after news, and -1.94% by the close. How OCEA actually reacts to news — the realized, point-in-time move the market made, measured across 91 labeled events over the last three years with zero look-ahead.
OCEA’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.29% | 32% | 87 |
| 30-min | -1.45% | 34% | 90 |
| 60-min | -2.07% | 31% | 90 |
| to close | -1.94% | 34% | 91 |
| Middle 50% of OCEA reactions | -4.60% to +0.92% |
|---|---|
| Median reaction (30-min) | -1.45% |
| Measured reactions | 91 |
Half of all Ocean Biomedical, Inc. news events land between -4.60% and +0.92% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when OCEA moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to OCEA's baseline. Nothing else.
Recent OCEA events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form NT 10-Q Ocean Biomedical, Inc. For: Jun 30 | SEC filing · Form NT | SEC EDGAR | +0.00% | -4.88% | |
| Form 8-K Ocean Biomedical, Inc. For: Jul 31 | SEC filing · Form 8-K | SEC EDGAR | +4.00% | +8.00% | |
| Form 8-K Ocean Biomedical, Inc. For: Jul 17 | SEC filing · Form 8-K | SEC EDGAR | -2.74% | +0.00% | |
| Form 8-K Ocean Biomedical, Inc. For: Jul 10 | SEC filing · Form 8-K | SEC EDGAR | -3.51% | +5.41% | |
| Form 8-K Ocean Biomedical, Inc. For: Jun 12 | SEC filing · Form 8-K | SEC EDGAR | -4.40% | -5.66% | |
| Form 10-Q Ocean Biomedical, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -2.70% | -6.81% | |
| Form 10-K/A Ocean Biomedical, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +7.79% | +41.56% | |
| Form 8-K Ocean Biomedical, Inc. For: Apr 22 | SEC filing · Form 8-K | SEC EDGAR | -16.11% | -43.06% | |
| Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value | Press release | GlobeNewswire | +1.92% | -7.67% | |
| Form 10-K Ocean Biomedical, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.22% | -7.71% | |
| Form 8-K Ocean Biomedical, Inc. For: Mar 28 | SEC filing · Form 8-K | SEC EDGAR | +12.34% | +14.50% | |
| Form NT 10-K Ocean Biomedical, Inc. For: Dec 31 | SEC filing · Form NT | SEC EDGAR | -0.58% | +6.39% | |
| Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China | Press release | GlobeNewswire | -6.75% | -23.37% | |
| Form 8-K Ocean Biomedical, Inc. For: Mar 26 | SEC filing · Form 8-K | SEC EDGAR | -6.44% | -23.90% | |
| Form 8-K Ocean Biomedical, Inc. For: Mar 14 | SEC filing · Form 8-K | SEC EDGAR | -4.92% | -1.43% | |
| Form 8-K Ocean Biomedical, Inc. For: Mar 04 | SEC filing · Form 8-K | SEC EDGAR | -0.88% | +6.00% | |
| Form DEFA14A Ocean Biomedical, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -0.88% | +6.00% | |
| Form 8-K Ocean Biomedical, Inc. For: Feb 20 | SEC filing · Form 8-K | SEC EDGAR | -5.07% | +4.14% | |
| Form DEF 14A Ocean Biomedical, Inc. For: Feb 26 | SEC filing · Form DEF | SEC EDGAR | -1.43% | -3.81% | |
| Form 8-K Ocean Biomedical, Inc. For: Feb 21 | SEC filing · Form 8-K | SEC EDGAR | -0.82% | -5.59% | |
| Form PRE 14A Ocean Biomedical, Inc. For: Feb 14 | SEC filing · Form PRE | SEC EDGAR | +0.38% | +9.65% | |
| Form 8-K Ocean Biomedical, Inc. For: Feb 11 | SEC filing · Form 8-K | SEC EDGAR | +2.77% | -3.81% | |
| Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development | Press release | GlobeNewswire | -12.88% | -33.36% | |
| Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway | Press release | GlobeNewswire | +4.02% | -58.44% | |
| Form 8-K Ocean Biomedical, Inc. For: Jan 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.65% | |
| Form 10-Q Ocean Biomedical, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +11.50% | +9.78% | |
| Form 10-Q Ocean Biomedical, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -5.21% | +0.69% | |
| Form 10-Q Ocean Biomedical, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -5.21% | +0.69% | |
| Form 8-K Ocean Biomedical, Inc. For: Dec 17 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -9.22% | |
| Form 8-K Ocean Biomedical, Inc. For: Dec 05 | SEC filing · Form 8-K | SEC EDGAR | +0.39% | -1.51% | |
| Form 8-K Ocean Biomedical, Inc. For: Dec 03 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.26% | |
| Form 8-K Ocean Biomedical, Inc. For: Dec 02 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.10% | |
| Form 10-K Ocean Biomedical, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.33% | +5.36% | |
| Form 8-K Ocean Biomedical, Inc. For: Nov 18 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.78% | |
| Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q | Press release | GlobeNewswire | +0.00% | -2.78% | |
| Form 8-K Ocean Biomedical, Inc. For: Oct 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.40% | |
| Form 8-K Ocean Biomedical, Inc. For: Oct 16 | SEC filing · Form 8-K | SEC EDGAR | +1.25% | -1.94% | |
| Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter | Press release | GlobeNewswire | +1.25% | -1.94% | |
| Form 8-K Ocean Biomedical, Inc. For: Oct 11 | SEC filing · Form 8-K | SEC EDGAR | -9.09% | -8.18% | |
| Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses | Press release | GlobeNewswire | -1.06% | -1.06% | |
| Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms | Press release | GlobeNewswire | +1.92% | -9.91% | |
| Form 8-K Ocean Biomedical, Inc. For: Aug 19 | SEC filing · Form 8-K | SEC EDGAR | +4.67% | -5.61% | |
| Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q | Press release | GlobeNewswire | +4.67% | -5.61% | |
| Form 8-K Ocean Biomedical, Inc. For: Jul 22 | SEC filing · Form 8-K | SEC EDGAR | -0.88% | +0.88% | |
| Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024 | Press release | GlobeNewswire | +2.61% | -1.01% | |
| Form 8-K Ocean Biomedical, Inc. For: May 22 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.88% | |
| Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q | Press release | GlobeNewswire | +0.00% | +2.88% | |
| Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease | Press release | GlobeNewswire | +1.16% | -1.73% | |
| Form NT 10-Q Ocean Biomedical, Inc. For: Mar 31 | SEC filing · Form NT | SEC EDGAR | — | +4.70% | |
| Form 8-K Ocean Biomedical, Inc. For: Apr 18 | SEC filing · Form 8-K | SEC EDGAR | -1.41% | -11.62% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the OCEA section they belong to.
Where else OCEA is measured.
OCEA earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Ocean Biomedical, Inc.'s median reaction calculated?
Every labeled OCEA news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 91 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 34% of OCEA's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does OCEA's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.